Table 1. Acute GVHD Grading Criteria.
Stage | Skin | Liver (bilirubin) | GI tract (stool output/day) |
---|---|---|---|
0 | No GVHD rash | < 2 mg/dl | Adult: < 500 ml/day Child: < 10 ml kg/day |
1 | Maculopapular rash < 25% BSA |
2–3 mg/dl | Adult: 500–999 ml/day Child: 10–19.9 ml/kg/day or persistent nausea, vomiting, or anorexia, with a positive upper GI biopsy |
2 | Maculopapular rash 25–50% BSA |
3.1–6 mg/dl | Adult: 1000–1500 ml/day Child: 20–30 ml/kg/day |
3 | Maculopapular rash > 50% BSA |
6.1–15 mg/dl | Adult: >1500 ml/day Child: > 30 ml/kg/day |
4 | Generalized erythroderma with bullous formation | > 15 mg/dl | Severe abdominal pain with or without ileus |
BSA = body surface area, GI = gastrointestinal, GVHD = graft versus host disease.
Overall Clinical Grade
0 | No stage 1–4 of any organ |
1 | Stage 1–2 skin rash and no liver or GI involvement |
2 | Stage 3 skin rash, or Stage 1 liver involvement, or Stage 1 GI involvement |
3 | Stage 0–3 skin rash, with Stage 2-3 liver involvement, and/or Stage 2–3 GI involvement |
4 | Stage 4 skin rash, liver, and/or GI involvement |